MORE►
AbbVie
Bridge Labs at Pegasus Park is at right with the campus's 18-story office tower literally bridged to it on the left. [Photo: Mauricio Rojas]
Cancer-Fighting Biotech to Move Research Operations to Dallas After ACS ‘Golden Ticket’ Win
by Lance Murray | Mar 24, 2025
Jibe Therapeutics is developing a next-generation cancer treatment that helps the immune system better recognize and attack tumors. As a result of its "Golden Ticket" pitch competition win, Jibe is relocating its research operations to Dallas' Pegasus Park.
by Glenn Hunter |
Oct 24, 2024
Fundraising has slowed and valuations are down, but biotech founders could have a lifeline in family office investments, panelists at the recent BioNTX summit in Arlington agreed. They said succeeding with these investors can take time, a lot of education, and a compelling, well-crafted story that connects emotionally with the family.
MORE►
by Lance Murray |
Oct 24, 2024
Oncology companies seeking seed-stage through Series A funding are invited to apply to the Golden Ticket Pitch Competition, which will be held on March 11, 2025.
MORE►
by Quincy Preston |
Jun 14, 2024
The North Texas chapter of the National Association of Corporate Directors has appointed Renee Arrington as board chair. Former Dallas Mayor Tom Leppert will serve as vice chair. The platform for corporate directorship, which helps members stay ahead of critical issues such as cyber risk and CEO succession planning, focuses on governance challenges and sharing knowledge.
MORE►
